Yuan Xu
Director/Board Member at AKERO THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Yuan J.
Xu is an Independent Director at Fate Therapeutics, Xilio Therapeutics, and Akero Therapeutics.
Previously, Xu served as the Chief Executive Officer & Director at Legend Biotech Corp., General Manager & Vice President-Biologics at Gilead Sciences, Senior Vice President at Merck & Co., and Vice President at Novartis AG.
Xu holds a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
-.--% | 2020-06-07 | 0 ( -.--% ) | - $ | 2024-03-30 |
Yuan Xu active positions
| Companies | Position | Start |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 2021-04-21 |
| FATE THERAPEUTICS, INC. | Director/Board Member | 2021-08-02 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 2022-01-03 |
Former positions of Yuan Xu
| Companies | Position | End |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Executive Officer | 2020-07-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2017-07-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2015-07-31 |
| NOVARTIS AG | Corporate Officer/Principal | 2013-12-31 |
Training of Yuan Xu
| University of Maryland | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| AKERO THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Yuan Xu
